TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Mary-Ellen Taplin, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

Dana-Farber/Harvard Cancer Center at Dana ...


Boston, Massachusetts - 02115 (617-632-4001)
  • CLINICAL TRIALS 7
  • CONDITIONS5
  • INTERVENTIONS17
  • SINCE2008
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

October 2009 - July 2012
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

September 2009 - April 2010
Ketoconazole Hydrocortisone Dutasteride and Lapatanib (KHAD-L) in Prostate Cancer

August 2009 - August 2011
Avastin Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy

April 2008 - April 2011
Metformin in Castration-Resistant Prostate Cancer

September 2010 - September 2012
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

October 2008 - August 2011
Neoadjuvant Abiraterone Acetate Plus Leuprolide Acetate in Men With Localized High Risk Prostate Cancer

September 2009 - December 2010
Prostatic Neoplasms

Neoplasm Metastasis

Bone Neoplasms

Bone Marrow Diseases

Recurrence

Bevacizumab

Docetaxel

Dasatinib

Avastin

Dutasteride

Bicalutamide

Leuprolide Acetate

Hydrocortisone

Imaging Biomarker Analysis

Metformin

Tok-001

Ketoconazole

Fluorine F 18 Sodium Fluoride

Lapatanib

Lupron Or Zoladex

Androgen Deprivation Therapy

Abiraterone Acetate Plus Leuprolide Acetate Plus Prednisone

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo